Your search returned 2459 results.

Results
	1521.	Inhibiting wild-type and C299S mutant AKR1B10; a homologue of aldose reductase upregulated in cancers. [electronic resource] by Verma, Malkhey Martin, Hans-Joerg Haq, Wahajul O'Connor, Timothy R Maser, Edmund Balendiran, Ganesaratnam K Producer: 20080701 In: European journal of pharmacology vol. 584 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1522.	Trapping of PARP1 and PARP2 by Clinical PARP Inhibitors. [electronic resource] by Murai, Junko Huang, Shar-yin N Das, Benu Brata Renaud, Amelie Zhang, Yiping Doroshow, James H Ji, Jiuping Takeda, Shunichi Pommier, Yves Producer: 20121231 In: Cancer research vol. 72 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1523.	The toxicity of nitrofuran compounds on melanoma and neuroblastoma cells is enhanced by Olaparib and ameliorated by melanin pigment. [electronic resource] by McNeil, Ewan M Ritchie, Ann-Marie Melton, David W Producer: 20140615 In: DNA repair vol. 12 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1524.	Design, synthesis and evaluation of dual pharmacology β2-adrenoceptor agonists and PDE4 inhibitors. [electronic resource] by Huang, Ling Shan, Wenjun Zhou, Qi Xie, Jiaxing Lai, Kefang Li, Xingshu Producer: 20140612 In: Bioorganic & medicinal chemistry letters vol. 24 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1525.	Yale Cancer Center Precision Medicine Tumor Board: two patients, one targeted therapy, different outcomes. [electronic resource] by Cecchini, Michael Walther, Zenta Sklar, Jeffrey L Bindra, Ranjit S Petrylak, Daniel P Eder, Joseph P Goldberg, Sarah B Producer: 20181126 In: The Lancet. Oncology vol. 19 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1526.	Olaparib monotherapy in patients with advanced relapsed ovarian cancer and a germline BRCA1/2 mutation: a multistudy analysis of response rates and safety. [electronic resource] by Matulonis, U A Penson, R T Domchek, S M Kaufman, B Shapira-Frommer, R Audeh, M W Kaye, S Molife, L R Gelmon, K A Robertson, J D Mann, H Ho, T W Coleman, R L Producer: 20171226 In: Annals of oncology : official journal of the European Society for Medical Oncology vol. 27 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1527.	Olaparib maintenance therapy in patients with platinum-sensitive, relapsed serous ovarian cancer and a BRCA mutation: Overall survival adjusted for postprogression poly(adenosine diphosphate ribose) polymerase inhibitor therapy. [electronic resource] by Matulonis, Ursula A Harter, Philipp Gourley, Charlie Friedlander, Michael Vergote, Ignace Rustin, Gordon Scott, Clare Meier, Werner Shapira-Frommer, Ronnie Safra, Tamar Matei, Daniela Fielding, Anitra Spencer, Stuart Parry, David Grinsted, Lynda Ledermann, Jonathan A Producer: 20170315 In: Cancer vol. 122 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1528.	Synthetically Lethal BMN 673 (Talazoparib) Loaded Solid Lipid Nanoparticles for BRCA1 Mutant Triple Negative Breast Cancer. [electronic resource] by Guney Eskiler, Gamze Cecener, Gulsah Egeli, Unal Tunca, Berrin Producer: 20181120 In: Pharmaceutical research vol. 35 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1529.	Using PARP Inhibitors in the Treatment of Patients With Ovarian Cancer. [electronic resource] by Kurnit, Katherine C Coleman, Robert L Westin, Shannon N Producer: 20191024 In: Current treatment options in oncology vol. 19 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1530.	Lead Optimization of Phthalazinone Phosphodiesterase Inhibitors as Novel Antitrypanosomal Compounds. [electronic resource] by Salado, Irene G Singh, Abhimanyu K Moreno-Cinos, Carlos Sakaine, Guna Siderius, Marco Van der Veken, Pieter Matheeussen, An van der Meer, Tiffany Sadek, Payman Gul, Sheraz Maes, Louis Sterk, Geert-Jan Leurs, Rob Brown, David Augustyns, Koen Producer: 20201007 In: Journal of medicinal chemistry vol. 63 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1531.	Enzymatic activation and trapping of luminol-substituted peptides and proteins. A possible means of amplifying the cytotoxicity of anti-tumor antibodies. [electronic resource] by Parker, C W Aach, R D Philpott, G W Producer: 19750611 In: Proceedings of the National Academy of Sciences of the United States of America vol. 72 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1532.	Efficacy of azelastine nasal spray in patients with an unsatisfactory response to loratadine. [electronic resource] by Berger, William E White, Martha V Producer: 20030930 In: Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology vol. 91 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1533.	In vitro and in vivo properties of dihydrophthalazine antifolates, a novel family of antibacterial drugs. [electronic resource] by Caspers, Patrick Bury, Luc Gaucher, Bérangère Heim, Jutta Shapiro, Stuart Siegrist, Sibylle Schmitt-Hoffmann, Anne Thenoz, Laure Urwyler, Heinrich Producer: 20091105 In: Antimicrobial agents and chemotherapy vol. 53 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1534.	Phase I pharmacokinetic study of the vascular endothelial growth factor receptor tyrosine kinase inhibitor vatalanib (PTK787) plus imatinib and hydroxyurea for malignant glioma. [electronic resource] by Reardon, David A Egorin, Merrill J Desjardins, Annick Vredenburgh, James J Beumer, Jan H Lagattuta, Theodore F Gururangan, Sridharan Herndon, James E Salvado, August J Friedman, Henry S Producer: 20090616 In: Cancer vol. 115 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1535.	[Effect of PKC signalling pathway and aldose reductase on expression of fibronectin induced by transforming growth factor-β1 in human mesangial cells]. [electronic resource] by Huang, Ping Zhang, Yue-juan Huang, Yuan Zhao, Jing-jing Jiang, Tao Zhang, Nong Producer: 20110414 In: Zhonghua bing li xue za zhi = Chinese journal of pathology vol. 39 Availability: No items available. Save to lists Add to cart (remove)
	1536.	Ferulic acid, a natural polyphenol, alleviates insulin resistance and hypertension in fructose fed rats: Effect on endothelial-dependent relaxation. [electronic resource] by El-Bassossy, Hany Badawy, Dina Neamatallah, Thikryat Fahmy, Ahmed Producer: 20170131 In: Chemico-biological interactions vol. 254 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1537.	[The effectiveness of the combination of azelastine hydrochloride and mometasone furoate for the intranasal application in the patients presenting with seasonal allergic rhinitis]. [electronic resource] by Karpishchenko, S A Kolesnikova, O M Producer: 20180315 In: Vestnik otorinolaringologii vol. 82 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1538.	Analysis of PARP inhibitor toxicity by multidimensional fluorescence microscopy reveals mechanisms of sensitivity and resistance. [electronic resource] by Michelena, Jone Lezaja, Aleksandra Teloni, Federico Schmid, Thomas Imhof, Ralph Altmeyer, Matthias Producer: 20181217 In: Nature communications vol. 9 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1539.	Effect of aldose reductase inhibitor (Ponalrestat) on erythrocyte Na,K-ATPase activity in non-insulin-dependent diabetic patients with polyneuropathy. [electronic resource] by Umeda, F Noda, K Hashimoto, T Yamashita, T Nawata, H Producer: 19900608 In: Diabetes research (Edinburgh, Scotland) vol. 12 Availability: No items available. Save to lists Add to cart (remove)
	1540.	Studies on peripheral nerve and lens in long-term experimental diabetes: effects of the aldose reductase inhibitor statil. [electronic resource] by Willars, G B Townsend, J Tomlinson, D R Compton, A M Churchill, R D Producer: 19880613 In: Metabolism: clinical and experimental vol. 37 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

First
Previous
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
Next
Last

Refine your search

Availability

Authors

Topics

Languages

Your search returned 2459 results.